|PS17||WEDNESDAY, 16 APRIL 2014||ROOM: 4
|Antimicrobial Resistance: A Global Health Challenge.
What Are the Integrated Solutions?
|Prof. Didier Pittet
Infection Control Programme, University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland
|Dr. Benedetta Allegranzi
Service Delivery and safety department, WHO, Switzerland
|Dr. Dominique Monnet
Senior Expert & Head of Programme, Antimicrobial Resistance & Healthcare-Associated Infections (ARHAI)
Office of the Chief Scientist,
European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
|Dr. Benedikt Huttner
Infection Control Programme, University of Geneva Hospitals, Geneva, Switzerland
|Dr. Jean Pierre Bru
Hôpital de Annecy, France
Didier Pittet, MD, MS, is the Hospital Epidemiologist and the Director of the Infection Control Programme at the University of Geneva Hospitals and Clinics (2500 beds), Geneva, Switzerland; Professor of Medicine and Hospital Epidemiology at the University of Geneva; and Attending Physician in Adult and Paediatric Infectious Diseases, University of Geneva Hospitals. He is also Visiting Professor, Division of Investigative Sciences and School of Medicine, Imperial College London, London, UK. Professor Pittet serves on the editorial boards of the American Journal of Infection Control, the American Journal of Respiratory and Critical Care Medecine, The Lancet Infectious Diseases and Infection Control and Hospital Epidemiology. He is also an editorial consultant of the Lancet. Professor Pittet currently leads the First Global Patient Safety Challenge “Clean Care is Safer Care” of the WHO World Alliance for Patient Safety. He was awarded the CBE in 2007 by Her Majesty Queen Elisabeth II for services to the prevention of healthcare-associated infection in the UK. Current major research interests include the epidemiology and prevention of nosocomial infections, methods for improving compliance with hand hygiene practices, and methods for improving the quality of patient care and patient safety.
Benedetta Allegranzi, MD, is a specialist in infectious diseases, tropical medicine, infection control and hospital epidemiology. She currently works at the World Health Organization (WHO) HQ (Service Delivery and Safety department), leading the “Clean Care is Safer Care” programme (http://www.who.int/gpsc/en/) focused on hand hygiene, infection control and antimicrobial resistance in health care. Since 2013, Dr Allegranzi has gathered the title of full professor of infectious diseases in the official Italian professorship list and is adjunct professor of public health at the Faculty of Medicine, University of Geneva, Switzerland. She closely collaborates with the team at the Infection Control Programme and WHO Collaborating Center on Patient Safety, University of Geneva Hospitals (Geneva, Switzerland), as well as with the Armstrong Institute for Patient Safety and Quality, John Hopkins University, (Baltimore, USA) for clinical research projects. She has experience in clinical management of infectious diseases and tropical medicine, and clinical research in healthcare settings in both developing and developed countries. She has thorough skills and experience in training and education.
She is the author or coauthor of more than 150 scientific publications, including articles published in high-profile medical journal such as the Lancet, Lancet Infectious Diseases, New England Journal of Medicine and the WHO Bulletin, and six book chapters.
Dr. Monnet received his degrees in pharmacy (PharmD) and clinical microbiology (PhD) from the University of Lyon, France, and then obtained further education as a hospital infection control specialist and epidemiologist.
Before joining ECDC in 2007, he worked in French hospitals, at the US Centers for Disease Control and Prevention (1993-1995) and at the Danish Statens Serum Institut (1997-2007) where he was coordinating surveillance of antimicrobial resistance and antimicrobial consumption in humans in Denmark.
His research interests include surveillance of antimicrobial resistance and antimicrobial consumption, the relationship between consumption of antimicrobials and resistance, and the factors that affect antimicrobial usage, both in hospitals and in primary care.
Dr Benedikt Huttner is an infectious disease physician at the Infection Control Program of Geneva University Hospitals.
After medical studies in Munich (Germany) and Nice (France) he came to Switzerland in 2002 to train in internal medicine (Ticino) and infectious diseases (Zurich and Geneva). After a short stay in pediatrics he joined the infection control of Geneva University Hospitals (Prof. Didier Pittet) in 2007. Between 2010 and 2012 Benedikt was a research fellow at the division of epidemiology of the University of Utah (Prof. Matthew Samore) and the VA Salt Lake City Health Care System. Benedikt’s research focuses on antibiotic stewardship and antimicrobial resistance, in the inpatient and outpatient setting. He is also an infectious disease consultant for the university’s geriatric hospital in Geneva.
MD, infectious diseases clinician, head of ID department at Annecy Hospital, a 1200 non-teaching French hospital.
Has experience in the management of infectious diseases, antimicrobial stewardship programs, and clinical research both in developing and developed countries.
Was expert in the field of antimicrobial treatments for twelve years at the French agency for medicine and health product safety.
Is editor in chief of ANTIBIOGARDE, a hospital digital guide that offer the particular feature to allow customization to serve as local frame of reference.